Inventor

AKIYOSHI KAZUNARI

JP11 patents

⚠️ This page may combine multiple inventors who share the name “AKIYOSHI KAZUNARI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV MIE

4 patents

US12569562B2Mar 10, 2026

Pretreatment drug for T cell infusion therapy for immune-checkpoint inhibitor-resistant tumor

UNIV MIE0 citations59

US11179450B2Nov 23, 2021

Long chain antigen containing interepitope sequence that promotes antigen presentation to T cells

UNIV MIE0 citations59

US11714068B2Aug 1, 2023

Exosome production method

UNIV MIE1 citations56

US11083744B2Aug 10, 2021

Therapeutic agent associated with suppression of proliferation and metastasis of tumor, which comprises exosomes released from cytotoxic T cells and targets cancer stromal/mesenchymal cells

UNIV MIE1 citations56

AKIYOSHI KAZUNARI

2 patents

US8759322B2Jun 24, 2014

Hyaluronic acid derivative and pharmaceutical composition thereof

AKIYOSHI KAZUNARI12 citations79

US8987230B2Mar 24, 2015

Hybrid gel comprising chemically crosslinked hyaluronic acid derivative and pharmaceutical composition comprising the same

AKIYOSHI KAZUNARI1 citations47

NOF CORP

1 patent

US6566516B1May 20, 2003

High purity polysaccharide containing a hydrophobic group and process for producing it

NOF CORP21 citations90

NAT UNIV CORP TOKYO MED & DENT

1 patent

US8961983B2Feb 24, 2015

Mucosal vaccine using cationic nanogel

NAT UNIV CORP TOKYO MED & DENT2 citations56

UNITED IMMUNITY CO LTD

1 patent

US12059471B2Aug 13, 2024

Complex

UNITED IMMUNITY CO LTD0 citations52

MORITA IKUO

1 patent

US9023384B2May 5, 2015

Liposome and method for injecting substance to cell using this liposome

MORITA IKUO1 citations49

LSIP LLC

1 patent

US9833407B2Dec 5, 2017

Nasal vaccine for Streptococcus pneumoniae

LSIP LLC1 citations45